Lucid Capital Markets Starts Adagio Medical Holdings (ADGM) at Buy, PT $3, 'Underserved $5.8B Market Only 6% Penetrated' Jun 3, 2026 07:05AM
Adagio Medical submits FDA application for heart arrhythmia device May 21, 2026 08:02AM
Adagio Medical reports positive pivotal trial results for heart device Apr 27, 2026 05:54AM
Piper Sandler Starts Adagio Medical Holdings (ADGM) at Overweight Apr 14, 2026 03:27AM
Adagio Medical gets FDA approval to expand ventricular ablation trial Apr 8, 2026 08:01AM


Feb 4, 2026 08:04AM Adagio Medical publishes study on ultralow temperature ablation for heart rhythm disorder
Dec 22, 2025 08:02AM Adagio Medical names two senior executives for commercial launch
Dec 2, 2025 08:39AM Lake Street Capital Markets Starts Adagio Medical Holdings (ADGM) at Buy
Nov 13, 2025 04:43PM Adagio Medical (ADGM) Misses Q3 EPS by 66c
Oct 20, 2025 08:00AM Adagio Medical closes $19 million financing for heart device development
Oct 10, 2025 03:40PM Adagio Medical reports 97% effectiveness in heart rhythm study
Oct 1, 2025 08:01AM Adagio Medical completes enrollment for pivotal trial of VT device
Sep 18, 2025 08:01AM Adagio Medical study results to be presented at VT symposium
Apr 17, 2025 08:33AM Adagio Medical Holdings (ADGM) Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation System
Mar 31, 2025 04:01PM Adagio Medical (ADGM) Appoints Deborah Kaster as Chief Business Officer
Mar 17, 2025 04:01PM Adagio Medical (ADGM) Provides Clinical and Business Updates
Feb 28, 2025 08:35AM Adagio Medical announces strategic restructuring
Dec 16, 2024 08:00AM Adagio Medical Holdings (ADGM) Appoints Todd Usen as CEO
Oct 24, 2024 08:31AM Adagio Medical (ADGM) Announces Completion of First Procedures in FULCRUM-VT U.S. FDA Pivotal IDE of Ventricular Tachycardia Cryoablation System
Aug 19, 2024 04:01PM Adagio Medical (ADGM) Provides Business Updates